10x Genomics (TXG) EBITDA Margin (2018 - 2026)
10x Genomics' (TXG) quarterly EBITDA Margin came in at 12.95% in Q2 2026, down 3037.0% year-over-year from 0.44% in Q2 2025, and down 14.57% quarter-over-quarter from 11.3% in Q1 2026.
Analysis
10x Genomics (TXG) EBITDA Margin (2018 - 2026) Analysis & Trends
10x Genomics has disclosed EBITDA Margin across 9 years of filings, most recently posting 12.95% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 3037.0% year-over-year to 12.95%; the TTM figure through Jun 2026 stood at 14.33% (up 127.0% YoY), while the FY2025 annual figure was 9.49%, up 2237.0% from the prior year.
- EBITDA Margin came in at 12.95% for Q2 2026 at 10x Genomics, down from 11.3% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 17.42% in Q2 2025 to a low of 61.7% in Q3 2023.
- Average EBITDA Margin over 5 years is 28.02%, with a median of 28.68% recorded in 2023.
- Year-over-year, EBITDA Margin tumbled 4616 bps in 2022 and jumped 4468 bps in 2025.
- Over 5 years, EBITDA Margin stood at 14.78% in 2022, then plunged by 103 bps to 30.0% in 2023, then slipped by 1 bps to 30.2% in 2024, then soared by 61 bps to 11.77% in 2025, then fell by 10 bps to 12.95% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 12.95% in Q2 2026, 11.3% in Q1 2026, and 11.77% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 6.85% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -7.79% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -12.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.95% |
| Mar 31, 2026 | -11.30% |
| Dec 31, 2025 | -11.77% |
| Sep 30, 2025 | -21.64% |
| Jun 30, 2025 | 17.42% |
| Mar 31, 2025 | -25.39% |
| Dec 31, 2024 | -30.20% |
| Sep 30, 2024 | -27.36% |
| Jun 30, 2024 | -27.26% |
| Mar 31, 2024 | -43.61% |
| Dec 31, 2023 | -30.00% |
| Sep 30, 2023 | -61.70% |
| Jun 30, 2023 | -43.15% |
| Mar 31, 2023 | -38.71% |
| Dec 31, 2022 | -14.78% |
| Sep 30, 2022 | -30.51% |
| Jun 30, 2022 | -55.07% |
| Mar 31, 2022 | -36.45% |
| Dec 31, 2021 | -11.03% |
| Sep 30, 2021 | -12.67% |